Temedica Stock

The future of health needs real insights.

Sign up today and learn more about Temedica Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Temedica Stock

Temedica is a Munich, Germany-based health insights company with the mission to enable personalized and individualized medicine, thereby focusing on patients and their individual needs. The company achieves this by operating an ecosystem for Real-World Evidence, offering aggregated and anonymized data on patient journeys and care realities to the pharma and biotech industries in an intuitive SaaS dashboard, which in turn, have an impact on real-world treatment adherence and effectiveness.

Funding History

January 2020$17.0M
November 2022$25.0M


Founder & CEO

Gloria Seibert

CMO & Co-Founder

Benjamin Friedrich

Board Member

Bernd Wendeln


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: